Rock Springs Capital Management LP Q1 2023 Filing

Filed May 15, 2023

Portfolio Value

$4.2B

Holdings

121

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (121 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	FATEFATE THERAPEUTICS INC	612,215	$3.0M	0.07%
102	ADAPYADAPTIMMUNE THERAPEUTICS PLC	2,787,845	$3.0M	0.07%
103	BEAMBEAM THERAPEUTICS INC	111,430	$3.0M	0.07%
104	—THESEUS PHARMACEUTICALS INC	437,329	$3.0M	0.07%
105	TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC	3,250,000	$3.0M	0.07%
106	DSGNDESIGN THERAPEUTICS INC	460,391	$2.0M	0.05%
107	ETNBGBP89BIO INC	164,500	$2.0M	0.05%	Call
108	FULCFULCRUM THERAPEUTICS INC	727,673	$2.0M	0.05%
109	EPIEURESSA PHARMA INC	524,944	$1.0M	0.02%
110	OVASUSDTEMPEST THERAPEUTICS INC	823,654	$1.0M	0.02%
111	GOSSGOSSAMER BIO INC	1,100,274	$1.0M	0.02%
112	NKTXNKARTA INC	393,389	$1.0M	0.02%
113	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.0M	0.02%
114	SPROSPERO THERAPEUTICS INC	669,533	$971K	0.02%
115	ALTALTIMMUNE INC	223,255	$942K	0.02%
116	VINCVINCERX PHARMA INC	891,719	$927K	0.02%
117	CGENCOMPUGEN LTD	1,289,990	$906K	0.02%
118	APLTAPPLIED THERAPEUTICS INC	780,791	$633K	0.02%
119	NVRO 2.75 04/01/25NEVRO CORP	500,000	$470K	0.01%
120	BCELATRECA INC	362,530	$413K	0.01%
121	TLPHACELRX PHARMACEUTICALS INC	316,460	$208K	0.00%

PreviousPage 2 of 2